Nomura Asset Management Co. Ltd. Acquires 8,622 Shares of Waters Corporation $WAT

Nomura Asset Management Co. Ltd. lifted its holdings in shares of Waters Corporation (NYSE:WAT) by 36.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,047 shares of the medical instruments supplier’s stock after buying an additional 8,622 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Waters were worth $11,186,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Zions Bancorporation National Association UT purchased a new stake in shares of Waters during the 1st quarter valued at about $28,000. IFP Advisors Inc lifted its position in Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after purchasing an additional 44 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in Waters in the first quarter worth approximately $41,000. Creative Financial Designs Inc. ADV grew its position in Waters by 533.3% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after purchasing an additional 160 shares during the period. Finally, Steph & Co. bought a new stake in Waters in the 2nd quarter worth approximately $73,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Trading Down 0.0%

Shares of WAT opened at $376.60 on Thursday. The company’s fifty day simple moving average is $336.45 and its 200-day simple moving average is $328.23. The company has a market cap of $22.42 billion, a P/E ratio of 33.96, a P/E/G ratio of 3.19 and a beta of 1.11. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. As a group, analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. TD Cowen increased their price target on Waters from $345.00 to $390.00 and gave the company a “hold” rating in a report on Wednesday, November 5th. Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Wells Fargo & Company raised their target price on Waters from $315.00 to $385.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 5th. Redburn Partners set a $390.00 price target on Waters in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Waters and gave the company a “hold” rating in a research report on Tuesday, August 5th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Waters has an average rating of “Moderate Buy” and an average price target of $381.57.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.